专利信息

首页 1 2 3 4 5 6 下页尾页共 303 条记录, 当前第1/31页。

专利标题：Extended-release pharmaceutical dosage forms of carbidopa and levodopa and processes of preparation thereof

The present invention relates to extended-release pharmaceutical dosage forms of carbidopa and levodopa comprising: a first component comprising a first portion of carbidopa and levodopa; a second component comprising a second portion of carbidopa and levodopa; and a third component comprising a third portion of carbidopa levodopa and carboxylic acid. The present invention also relates to processes for the preparation of said extended-release pharmaceutical dosage forms. The present invention fu...

专利标题：Compound sustained-released suspensoid of levodopa/carbidopa and preparation method thereof

专利标题：Method to individualize levodopa/carbidopa therapy using a breath test

专利标题：Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same

专利权人：Neuroderm, Ltd.;

Provided herein in part is a method of treating a neurological or movement disorder in a patient in need thereof comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone or pharmaceutically acceptable salts thereof wherein said composition is administered substantially continuously and compositions that can be used in the disclosed methods.

专利标题：Extended-release pharmaceutical dosage forms of carbidopa and levodopa and processes of preparation thereof

专利权人：RANBAXY LABORATORIES LIMITED;

专利标题：Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same

专利权人：Neuroderm Ltd.;

专利标题：Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same

专利权人：Neuroderm Ltd.;

专利标题：Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability

专利权人：Wockhardt Research Centre;

The present invention relates to single oral dose pharmaceutical compositions comprising a combination of entacapone levodopa and carbidopa or salts thereof along with one or more sugar alcohols wherein the entacapone is co-micronized with one or more sugar alcohols. The composition of the invention exhibits bioequivalence to commercially available entacapone levodopa and carbidopa combination formulation marketed under the trade name Stalevo200

专利标题：Tablet formulation comprising levodopa, carbidopa, entacapone providing extended release

The present invention is related to a composition intended for the treatment of Parkinson disease which comprises levodopa carbidopa entacapone or pharmaceutically acceptable salts solvates or hydrates of these molecules in a combined form. The invention is characterized in that it comprises both levodopa and carbidopa as extended release form and entacapon as immediately release form.

当前查询条件: [药品] 包含 'Carbidopa'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. WO2014006571A3	2014/3/20	WO2013IB55433	2013/7/2
专利标题：Extended-release pharmaceutical dosage forms of carbidopa and levodopa and processes of preparation thereof 专利权人：RANBAXY LABORATORIES LIMITED; The present invention relates to extended-release pharmaceutical dosage forms of carbidopa and levodopa comprising: a first component comprising a first portion of carbidopa and levodopa; a second component comprising a second portion of carbidopa and levodopa; and a third component comprising a third portion of carbidopa levodopa and carboxylic acid. The present invention also relates to processes for the preparation of said extended-release pharmaceutical dosage forms. The present invention fu...

2. CN103622942A	2014/3/12	CN20131538946	2013/11/4
专利标题：Compound sustained-released suspensoid of levodopa/carbidopa and preparation method thereof 专利权人：

3. EP1898961B1	2014/2/26	EP20060780854	2006/6/30
专利标题：Method to individualize levodopa/carbidopa therapy using a breath test 专利权人：Otsuka America Pharmaceutical, Inc.;

4. US20140051755A1	2014/2/20	US13/885518	2011/11/15
专利标题：Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same 专利权人：Neuroderm, Ltd.; Provided herein in part is a method of treating a neurological or movement disorder in a patient in need thereof comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone or pharmaceutically acceptable salts thereof wherein said composition is administered substantially continuously and compositions that can be used in the disclosed methods.

5. WO2014006571A2	2014/1/9	WO2013IB55433	2013/7/2
专利标题：Extended-release pharmaceutical dosage forms of carbidopa and levodopa and processes of preparation thereof 专利权人：RANBAXY LABORATORIES LIMITED; The present invention relates to extended-release pharmaceutical dosage forms of carbidopa and levodopa comprising: a first component comprising a first portion of carbidopa and levodopa; a second component comprising a second portion of carbidopa and levodopa; and a third component comprising a third portion of carbidopa levodopa and carboxylic acid. The present invention also relates to processes for the preparation of said extended-release pharmaceutical dosage forms. The present invention fu...

6. JP2013545745A	2013/12/26	JP20130538326	2011/11/15
专利标题：专利权人： Provided herein in part is a method of treating a neurological or movement disorder in a patient in need thereof comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone or pharmaceutically acceptable salts thereof wherein said composition is administered substantially continuously and compositions that can be used in the disclosed methods.

7. KR20130140075A	2013/12/23	KR20137015306	2011/11/15
专利标题：Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same 专利权人：Neuroderm Ltd.; Provided herein in part is a method of treating a neurological or movement disorder in a patient in need thereof comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone or pharmaceutically acceptable salts thereof wherein said composition is administered substantially continuously and compositions that can be used in the disclosed methods.

8. CN103442693A	2013/12/11	CN2011864894	2011/11/15
专利标题：Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same 专利权人：Neuroderm Ltd.;

9. AU2009211028B2	2013/12/5	AU20090211028	2009/2/6
专利标题：Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability 专利权人：Wockhardt Research Centre; The present invention relates to single oral dose pharmaceutical compositions comprising a combination of entacapone levodopa and carbidopa or salts thereof along with one or more sugar alcohols wherein the entacapone is co-micronized with one or more sugar alcohols. The composition of the invention exhibits bioequivalence to commercially available entacapone levodopa and carbidopa combination formulation marketed under the trade name Stalevo200

10. EP2656856A2	2013/10/30	EP20130002069	2013/4/19
专利标题：Tablet formulation comprising levodopa, carbidopa, entacapone providing extended release 专利权人：Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi; The present invention is related to a composition intended for the treatment of Parkinson disease which comprises levodopa carbidopa entacapone or pharmaceutically acceptable salts solvates or hydrates of these molecules in a combined form. The invention is characterized in that it comprises both levodopa and carbidopa as extended release form and entacapon as immediately release form.

下载范围

下载内容